Optimized MLPA workflow for spinal muscular atrophy diagnosis: identification of a novel variant, NC_000005.10:g.(70919941_70927324)del in isolated exon 1 of SMN1 gene through long-range PCR.
Yao. Mei M; Jiang. Liya L; Yu. Yicheng Y; Cui. Yiqin Y; Chen. Yuwei Y; Zhou. Dongming D; Gao. Feng F; Mao. Shanshan S
Key Findings
- A novel deletion (g.70919941_70927324del) removing exon 1 of SMN1 was identified.
- Both families shared the exact breakpoint, suggesting a possible mutation hotspot.
- An optimized MLPA P021 workflow combined with long‑range PCR and third‑generation sequencing reliably detects this single‑exon loss.
Practical Outcomes
- The new testing approach makes it easier and cheaper to diagnose SMA caused by exon‑1 deletions, but it does not provide actionable strategies for longevity, metabolic health, or performance enhancement for the general biohacker community.
Summary
Scientists improved a lab test to spot a rare genetic change that causes spinal muscular atrophy, finding a new 7.3 kb deletion in the SMN1 gene that appears in two unrelated Chinese families.
Abstract
Spinal muscular atrophy (SMA) is a rare autosomal recessive hereditary neuromuscular disease caused by survival motor neuron 1 (SMN1) gene deletion or mutation. Homozygous deletions of exon 7 in SMN1 result in 95% of SMA cases, while the remaining 5% are caused by other pathogenic variants of SMN1. We analyzed two SMA-suspected cases that were collected, with no SMN1 gene deletion and point mutation in whole-exome sequencing. Exon 1 deletion of the SMN gene was detected using Multiplex ligation-dependent probe amplification (MLPA) P021. We used long-range polymerase chain reaction (PCR) to isolate the SMN1 template, optimized-MLPA P021 for copy number variation (CNV) analysis within SMN1 only, and validated the findings via third-generation sequencing. Two unrelated families shared a genotype with one copy of exon 7 and a novel variant, g.70919941_70927324del, in isolated exon 1 of the SMN1 gene. Case F1-II.1 demonstrated no exon 1 but retained other exons, whereas F2-II.1 had an exon 1 deletion in a single SMN1 gene. The read coverage in the third-generation sequencing results of both F1-II.1 and F2-II.1 revealed a deletion of approximately 7.3 kb in the 5' region of SMN1. The first nucleotide in the sequence data aligned to the 7385 bp of NG_008691.1. Remarkably, two proband families demonstrated identical SMN1 exon 1 breakpoint sites, hinting at a potential novel mutation hotspot in Chinese SMA, expanding the variation spectrum of the SMN1 gene and corroborating the specificity of isolated exon 1 deletion in SMA pathogenesis. The optimized-MLPA P021 determined a novel variant (g.70919941_70927324del) in isolated exon 1 of the SMN1 gene based on long-range PCR, enabling efficient and affordable detection of SMN gene variations in patients with SMA, providing new insight into SMA diagnosis to SMN1 deficiency and an optimized workflow for single exon CNV testing of the SMN gene.
Study Information
pubmed
2024
2024-03-11T00:00:00.000Z
10.1186/s12883-024-03592-5
3
32